Skip to content
facebook
twitter
linkedin
youtube
Toggle navigation
L36, 1 Macquarie Place, Sydney, NSW 2000
+61 2 8051 3043
info@raceoncology.com
Home
About
Science
Management team
Investors
News
CONTACT US
×
Contact Us
Δ
Race CEO Phil Lynch Talks with Proactive at the ASX Small and Mid-Cap Conference
Browse
Home
Featured
Race CEO Phil Lynch Talks with Proactive at the ASX Small and Mid-Cap Conference
16
Mar
Mar
, 16 ,
2022
Daniel Tillett
Facebook
Tweet
LinkedIn
Related posts:
Race Oncology ASX Small and Mid Cap Conference Presentation
CSO Dr Daniel Tillett talks to Proactive about recent kidney cancer results
CEO Phil Lynch Talks to the Australian Shareholder Association Podcast
Post navigation
Previous
Previous post:
Next
Next post:
Race Oncology
Targeting Zantrene® towards better cancer outcomes
Contact Us
©2021 Race Oncology Ltd